Latest Breaking News On - Mary anne heino - Page 12 : comparemela.com

Lantheus Reports Preliminary Fiscal Year 2023 Revenue

Full year 2023 worldwide revenue expected to be in the range of $1.295 – 1.297 billion, a 38 - 39% increase over the prior year including a $15 million.

United statesNew jerseyMary anne heinoMark kinarneyBiopharma global incSecurities exchangeExchange commissionLantheus holdings incChief executive officerPrivate securities litigation reform actSecurities actSecurities exchange actGlobal incRisk factorsAnnual reportsQuarterly reports

Perspective Therapeutics (CATX) Enters into Strategic Agreements with Lantheus (LNTH) Including Equity Investment, Co-Development Options

Perspective Therapeutics (CATX) Enters into Strategic Agreements with Lantheus (LNTH) Including Equity Investment, Co-Development Options
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesMary anne heinoThijs spoorPerspective therapeutics incLantheus holdings incLantheus holdingsChief executive officerPerspective therapeutics

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

Lantheus will have the option to negotiate an exclusive license to Perspective Therapeutics’ Pb212-VMT-α-NETLantheus will have the option to co-fund and negotiate an exclusive license for certain.

United statesNew jerseyMary anne heinoThijs spoorPerspective therapeutics incLantheus holdings incDepartment of energyExchange commissionPerspective therapeuticsPerspective therapeuticLantheus holdingsChief executive officerTransition reportQuarterly report

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Option to license Perspective Therapeutics’ Pb212-VMT-α-NET asset Co-development rights for certain Pb212-based alpha therapies for prostate cancer Equity investment of up to 19.9% in.

United statesNew jerseyThijs spoorMark kinarneyMary anne heinoSecurities exchangePerspective therapeutics incLantheus holdings incExchange commissionPerspective therapeuticsChief executive officerPerspective therapeuticPrivate securities litigation reform actSecurities actSecurities exchange actRisk factors

Lantheus Holdings, Inc (NASDAQ:LNTH) Holdings Raised by Eagle Health Investments LP

Eagle Health Investments LP increased its position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 64.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 416,700 shares of the medical equipment provider’s stock after acquiring an additional 163,500 shares […]

Mary anne heinoWilliam blairPaul blanchfieldLantheus holdings incVanguard group incNorges bankEagle health investmentsExchange commissionLantheus holdingsFree reportHealth investmentsStock downGet free reportPresident paul blanchfieldAnne heinoTruist financial